palmidrol has been researched along with Anorexia Nervosa in 2 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
Anorexia Nervosa: An eating disorder that is characterized by the lack or loss of APPETITE, known as ANOREXIA. Other features include excess fear of becoming OVERWEIGHT; BODY IMAGE disturbance; significant WEIGHT LOSS; refusal to maintain minimal normal weight; and AMENORRHEA. This disorder occurs most frequently in adolescent females. (APA, Thesaurus of Psychological Index Terms, 1994)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Scolnick, B | 1 |
Monteleone, AM | 1 |
Di Marzo, V | 1 |
Aveta, T | 1 |
Piscitelli, F | 1 |
Dalle Grave, R | 1 |
Scognamiglio, P | 1 |
El Ghoch, M | 1 |
Calugi, S | 1 |
Monteleone, P | 1 |
Maj, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Hunger and Satiety Perception in Patients With Anorexia Nervosa[NCT02932046] | 47 participants (Actual) | Observational | 2014-02-28 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 other studies available for palmidrol and Anorexia Nervosa
Article | Year |
---|---|
Treatment of anorexia nervosa with palmitoylethanoamide.
Topics: Amides; Animals; Anorexia Nervosa; Arachidonic Acids; Dietary Fats; Dietary Supplements; Endocannabi | 2018 |
Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa.
Topics: Adolescent; Adult; Amides; Anorexia Nervosa; Arachidonic Acids; Case-Control Studies; Endocannabinoi | 2015 |